There are 100k brain metastasis
per year, and lung cancer
patients compose about half of them. It is a very common first site of relapse, and can have serious consequences.
Preventitive brain radiotherapy is indicated in all responders in small cell, but the trial in non-sclc showed reduction in frequency of brain metastases, but no survival benefit. Thus, many insurers will not pay for it.